Evidence map›Paper›PMID 41112420›Full record

ArticleJournal of cancer prevention2025

Development of Primary Colon and Duodenal Tumor Cultures from the Apc-mutant Pirc Rat for Screening Preventive Agents.

Ahmed Muhsin, Sultan Neja, Nivedhitha Mohan, Sabeeta Kapoor, Jorge Enrique Tovar Perez, Wan-Mohaiza Dashwood, Asif Rashid, Roderick Dashwood, Praveen Rajendran

Abstract read
In one paragraph

Article in Journal of cancer prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed MuhsinCenter for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0000-0002-5834-9921
Sultan NejaCenter for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0000-0003-3972-0016
Nivedhitha MohanCenter for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0009-0006-5307-6975
Sabeeta KapoorCenter for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0000-0001-7906-3343
Jorge Enrique Tovar PerezCenter for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0009-0000-4004-8736
Wan-Mohaiza DashwoodCenter for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0009-0005-6636-3394
Asif RashidDepartment of Pathology, Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-2922-8768
Roderick Dashwood *Center for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0000-0003-0351-4034
Praveen Rajendran *Center for Epigenetics & Disease Prevention, Texas A&M Health, Houston, TX, USA.ORCID https://orcid.org/0000-0002-6221-7366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with genetic, epigenetic, and immune-dependent mechanisms contributing to disease pathogenesis. Preventive strategies are especially important for individuals with hereditary syndromes such as familial adenomatous polyposis (FAP), in which

Indexed as

Adenomatous polyposis coliChemopreventionColorectal neoplasmsPrimary cell cultureRats

Identifiers

PMID41112420
PMCPMC12527970

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.